| 0 |
LYSOSOMAL STORAGE DISORDER |
7 |
0.3684 |
| 1 |
PLASMA CELL MYELOMA IN REMISSION |
3 |
0.0577 |
| 2 |
HEREDITARY ANGIOEDEMA |
607 |
0.0565 |
| 3 |
PANTOEA AGGLOMERANS INFECTION |
4 |
0.0519 |
| 4 |
PRODUCT COMPOUNDING QUALITY ISSUE |
16 |
0.0438 |
| 5 |
HYDROSALPINX |
4 |
0.0435 |
| 6 |
GLYCOGEN STORAGE DISEASE TYPE II |
4 |
0.0381 |
| 7 |
THYROID STIMULATING IMMUNOGLOBULIN INCREASED |
3 |
0.0375 |
| 8 |
USE OF ACCESSORY RESPIRATORY MUSCLES |
14 |
0.0339 |
| 9 |
DEAFNESS PERMANENT |
6 |
0.0306 |
| 10 |
CATHETER SITE DISCOMFORT |
2 |
0.0250 |
| 11 |
CATHETERISATION VENOUS |
2 |
0.0244 |
| 12 |
IN VITRO FERTILISATION |
4 |
0.0221 |
| 13 |
CATHETER SITE THROMBOSIS |
6 |
0.0219 |
| 14 |
OVARIAN HYPERSTIMULATION SYNDROME |
50 |
0.0214 |
| 15 |
CATHETER REMOVAL |
7 |
0.0196 |
| 16 |
WRONG PRODUCT STORED |
5 |
0.0176 |
| 17 |
CENTRAL VENOUS CATHETER REMOVAL |
8 |
0.0171 |
| 18 |
GRANULOCYTE COUNT DECREASED |
31 |
0.0167 |
| 19 |
ENTEROBACTER TEST POSITIVE |
4 |
0.0163 |
| 20 |
CATHETER SITE VESICLES |
3 |
0.0154 |
| 21 |
GLOBOTRIAOSYLSPHINGOSINE INCREASED |
3 |
0.0153 |
| 22 |
LIP INFECTION |
3 |
0.0142 |
| 23 |
VASCULAR ACCESS COMPLICATION |
11 |
0.0136 |
| 24 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
12 |
0.0134 |
| 25 |
PACKAGING DESIGN ISSUE |
4 |
0.0122 |
| 26 |
CATHETER SITE IRRITATION |
4 |
0.0120 |
| 27 |
DRUG LABEL CONFUSION |
3 |
0.0120 |
| 28 |
VASCULAR DEVICE OCCLUSION |
4 |
0.0118 |
| 29 |
PRODUCT PACKAGING CONFUSION |
27 |
0.0111 |
| 30 |
ALLERGY TO PLANTS |
5 |
0.0109 |
| 31 |
ENDOCRINE OPHTHALMOPATHY |
9 |
0.0104 |
| 32 |
ANTIBIOTIC LEVEL ABOVE THERAPEUTIC |
4 |
0.0099 |
| 33 |
ANHIDROSIS |
4 |
0.0098 |
| 34 |
DEVICE RELATED BACTERAEMIA |
3 |
0.0097 |
| 35 |
POOR VENOUS ACCESS |
92 |
0.0089 |
| 36 |
INFUSION SITE DISCOMFORT |
9 |
0.0087 |
| 37 |
NEONATAL INFECTION |
3 |
0.0087 |
| 38 |
STIFF PERSON SYNDROME |
3 |
0.0086 |
| 39 |
CATHETER SITE SWELLING |
8 |
0.0085 |
| 40 |
FACIAL DISCOMFORT |
6 |
0.0085 |
| 41 |
MEDICAL DEVICE SITE INFECTION |
5 |
0.0081 |
| 42 |
PRODUCT BARCODE ISSUE |
3 |
0.0078 |
| 43 |
PRODUCT APPEARANCE CONFUSION |
7 |
0.0076 |
| 44 |
CATHETER SITE EXTRAVASATION |
3 |
0.0075 |
| 45 |
NAIL OPERATION |
3 |
0.0072 |
| 46 |
NEUTRALISING ANTIBODIES POSITIVE |
3 |
0.0072 |
| 47 |
PRODUCT CLOSURE ISSUE |
4 |
0.0072 |
| 48 |
CATHETER SITE PRURITUS |
6 |
0.0068 |
| 49 |
VASCULAR DEVICE INFECTION |
30 |
0.0066 |
| 50 |
MYELOSUPPRESSION |
238 |
0.0066 |
| 51 |
TRACHEITIS |
5 |
0.0066 |
| 52 |
CATHETER SITE PAIN |
17 |
0.0065 |
| 53 |
PRODUCT SELECTION ERROR |
7 |
0.0064 |
| 54 |
INFUSION SITE HAEMATOMA |
3 |
0.0063 |
| 55 |
CENTRAL VENOUS CATHETERISATION |
19 |
0.0063 |
| 56 |
PERIARTHRITIS |
14 |
0.0061 |
| 57 |
CATHETER SITE BRUISE |
2 |
0.0060 |
| 58 |
URINARY TRACT PAIN |
3 |
0.0059 |
| 59 |
INFUSION SITE VESICLES |
3 |
0.0057 |
| 60 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
5 |
0.0056 |
| 61 |
LARYNGEAL DISORDER |
4 |
0.0055 |
| 62 |
CATHETER PLACEMENT |
10 |
0.0054 |
| 63 |
VEIN RUPTURE |
9 |
0.0054 |
| 64 |
ADMINISTRATION SITE PAIN |
6 |
0.0052 |
| 65 |
INFUSION SITE EXTRAVASATION |
32 |
0.0051 |
| 66 |
ASYMPTOMATIC COVID-19 |
2 |
0.0051 |
| 67 |
CROUP INFECTIOUS |
4 |
0.0051 |
| 68 |
PRODUCT CONTAMINATION MICROBIAL |
6 |
0.0050 |
| 69 |
CAT SCRATCH DISEASE |
2 |
0.0050 |
| 70 |
INFUSION SITE SWELLING |
31 |
0.0049 |
| 71 |
PRODUCT PREPARATION ISSUE |
31 |
0.0047 |
| 72 |
LARYNGEAL OEDEMA |
29 |
0.0047 |
| 73 |
INSURANCE ISSUE |
71 |
0.0046 |
| 74 |
SPINAL CORD INFECTION |
3 |
0.0046 |
| 75 |
INFUSION SITE URTICARIA |
3 |
0.0045 |
| 76 |
DEVICE RELATED SEPSIS |
9 |
0.0045 |
| 77 |
BLOOD MAGNESIUM INCREASED |
4 |
0.0044 |
| 78 |
ALLERGY TO ARTHROPOD STING |
2 |
0.0044 |
| 79 |
MAST CELL ACTIVATION SYNDROME |
6 |
0.0043 |
| 80 |
HAEMATOLOGICAL INFECTION |
10 |
0.0041 |
| 81 |
CATHETER SITE INFECTION |
15 |
0.0040 |
| 82 |
INFUSION SITE IRRITATION |
5 |
0.0039 |
| 83 |
PRESCRIBED OVERDOSE |
74 |
0.0038 |
| 84 |
IDIOPATHIC URTICARIA |
4 |
0.0037 |
| 85 |
INFUSION SITE REACTION |
11 |
0.0037 |
| 86 |
INFUSION SITE PAIN |
47 |
0.0036 |
| 87 |
INFUSION SITE RASH |
5 |
0.0036 |
| 88 |
HAND-FOOT-AND-MOUTH DISEASE |
3 |
0.0036 |
| 89 |
POOR QUALITY PRODUCT ADMINISTERED |
38 |
0.0036 |
| 90 |
DEVICE RELATED INFECTION |
55 |
0.0036 |
| 91 |
BUNION OPERATION |
2 |
0.0036 |
| 92 |
BLOOD FIBRINOGEN DECREASED |
4 |
0.0035 |
| 93 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
19 |
0.0035 |
| 94 |
NOROVIRUS INFECTION |
5 |
0.0035 |
| 95 |
TENSION |
21 |
0.0034 |
| 96 |
INFUSION SITE INFECTION |
8 |
0.0034 |
| 97 |
INFUSION SITE DISCOLOURATION |
3 |
0.0034 |
| 98 |
FEBRILE INFECTION |
4 |
0.0034 |
| 99 |
PRODUCT CONTAMINATION |
12 |
0.0034 |
| 100 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
3 |
0.0034 |
| 101 |
DEAFNESS NEUROSENSORY |
11 |
0.0033 |
| 102 |
ALLERGY TO METALS |
2 |
0.0033 |
| 103 |
CERUMEN IMPACTION |
3 |
0.0033 |
| 104 |
CATHETER SITE ERYTHEMA |
7 |
0.0033 |
| 105 |
INFUSION SITE WARMTH |
4 |
0.0033 |
| 106 |
ALLERGY TO CHEMICALS |
4 |
0.0032 |
| 107 |
PSYCHOGENIC SEIZURE |
3 |
0.0032 |
| 108 |
OVARIAN CYST RUPTURED |
4 |
0.0031 |
| 109 |
SPINAL LAMINECTOMY |
3 |
0.0031 |
| 110 |
CYSTIC FIBROSIS |
17 |
0.0031 |
| 111 |
INCORRECT DRUG ADMINISTRATION RATE |
13 |
0.0031 |
| 112 |
PHARYNGITIS STREPTOCOCCAL |
33 |
0.0030 |
| 113 |
DEVICE RELATED THROMBOSIS |
3 |
0.0030 |
| 114 |
INFUSION SITE HAEMORRHAGE |
10 |
0.0030 |
| 115 |
DELIVERY |
2 |
0.0030 |
| 116 |
GLYCOSURIA |
4 |
0.0030 |
| 117 |
SIALOADENITIS |
4 |
0.0029 |
| 118 |
PRODUCT LABEL CONFUSION |
17 |
0.0029 |
| 119 |
DERMATITIS CONTACT |
32 |
0.0028 |
| 120 |
RENAL TRANSPLANT |
10 |
0.0028 |
| 121 |
POST PROCEDURAL SWELLING |
3 |
0.0027 |
| 122 |
INFUSION SITE ERYTHEMA |
23 |
0.0027 |
| 123 |
CATHETER SITE DISCHARGE |
3 |
0.0027 |
| 124 |
CARDIAC INFECTION |
2 |
0.0027 |
| 125 |
BLOODY DISCHARGE |
3 |
0.0026 |
| 126 |
WRONG DRUG ADMINISTERED |
23 |
0.0026 |
| 127 |
INFERTILITY FEMALE |
4 |
0.0026 |
| 128 |
PRURITUS ALLERGIC |
3 |
0.0026 |
| 129 |
PRODUCT DEPOSIT |
4 |
0.0026 |
| 130 |
SKIN ABRASION |
12 |
0.0025 |
| 131 |
PHYSICAL PRODUCT LABEL ISSUE |
3 |
0.0025 |
| 132 |
CHRONIC RESPIRATORY FAILURE |
3 |
0.0025 |
| 133 |
WEIGHT FLUCTUATION |
26 |
0.0025 |
| 134 |
DEVICE INFUSION ISSUE |
6 |
0.0024 |
| 135 |
PRODUCT CONTAMINATION PHYSICAL |
6 |
0.0024 |
| 136 |
EXPOSURE TO SARS-COV-2 |
4 |
0.0024 |
| 137 |
EXOPHTHALMOS |
5 |
0.0023 |
| 138 |
INFUSION SITE BRUISING |
5 |
0.0023 |
| 139 |
TREATMENT DELAYED |
4 |
0.0023 |
| 140 |
ABSCESS DRAINAGE |
2 |
0.0023 |
| 141 |
INTERCEPTED PRODUCT SELECTION ERROR |
3 |
0.0023 |
| 142 |
INFUSION SITE DISCHARGE |
4 |
0.0023 |
| 143 |
WISDOM TEETH REMOVAL |
3 |
0.0023 |
| 144 |
GASTROENTERITIS VIRAL |
40 |
0.0022 |
| 145 |
MULTIPLE ALLERGIES |
17 |
0.0022 |
| 146 |
POOR QUALITY DRUG ADMINISTERED |
14 |
0.0022 |
| 147 |
DENTAL CARE |
4 |
0.0022 |
| 148 |
SINUS PAIN |
5 |
0.0021 |
| 149 |
APPENDIX DISORDER |
3 |
0.0021 |
| 150 |
OXYGEN SATURATION ABNORMAL |
6 |
0.0021 |
| 151 |
WEIGHT ABNORMAL |
5 |
0.0021 |
| 152 |
BUTTERFLY RASH |
2 |
0.0020 |
| 153 |
PRODUCT COLOUR ISSUE |
10 |
0.0019 |
| 154 |
PRODUCT PREPARATION ERROR |
40 |
0.0019 |
| 155 |
CHEST INJURY |
4 |
0.0019 |
| 156 |
LIQUID PRODUCT PHYSICAL ISSUE |
14 |
0.0019 |
| 157 |
INFUSION SITE PRURITUS |
6 |
0.0019 |
| 158 |
PHARYNGEAL PARAESTHESIA |
3 |
0.0019 |
| 159 |
HYPERPYREXIA |
8 |
0.0019 |
| 160 |
ANIMAL BITE |
5 |
0.0019 |
| 161 |
PARANASAL SINUS DISCOMFORT |
7 |
0.0018 |
| 162 |
DRUG SPECIFIC ANTIBODY PRESENT |
12 |
0.0018 |
| 163 |
RESPIRATORY TRACT INFECTION |
48 |
0.0018 |
| 164 |
SEASONAL ALLERGY |
26 |
0.0018 |
| 165 |
PRODUCT DISTRIBUTION ISSUE |
17 |
0.0018 |
| 166 |
COLONOSCOPY |
4 |
0.0018 |
| 167 |
ARTHROPOD STING |
3 |
0.0018 |
| 168 |
VEIN DISORDER |
9 |
0.0018 |
| 169 |
RHINOVIRUS INFECTION |
7 |
0.0018 |
| 170 |
STREPTOCOCCAL INFECTION |
10 |
0.0018 |
| 171 |
TONSILLAR HYPERTROPHY |
3 |
0.0018 |
| 172 |
PRODUCT LEAKAGE |
10 |
0.0018 |
| 173 |
EAR INFECTION |
47 |
0.0018 |
| 174 |
PRODUCT CONTAINER ISSUE |
15 |
0.0017 |
| 175 |
LIGAMENT SPRAIN |
17 |
0.0017 |
| 176 |
SINUS CONGESTION |
23 |
0.0017 |
| 177 |
INGROWING NAIL |
4 |
0.0017 |
| 178 |
FIBRIN D DIMER INCREASED |
6 |
0.0017 |
| 179 |
JUGULAR VEIN THROMBOSIS |
3 |
0.0017 |
| 180 |
GASTROINTESTINAL INFECTION |
15 |
0.0017 |
| 181 |
PRODUCT LABEL ISSUE |
11 |
0.0016 |
| 182 |
CATHETER SITE HAEMORRHAGE |
4 |
0.0016 |
| 183 |
GINGIVAL RECESSION |
3 |
0.0016 |
| 184 |
HAND FRACTURE |
11 |
0.0016 |
| 185 |
HERNIA REPAIR |
4 |
0.0015 |
| 186 |
URINE OUTPUT INCREASED |
4 |
0.0015 |
| 187 |
COMPLICATION ASSOCIATED WITH DEVICE |
22 |
0.0015 |
| 188 |
EXPOSURE VIA BREAST MILK |
6 |
0.0015 |
| 189 |
NEUTROPHIL COUNT DECREASED |
61 |
0.0015 |
| 190 |
PHARYNGEAL OEDEMA |
23 |
0.0015 |
| 191 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
6 |
0.0015 |
| 192 |
BONE MARROW FAILURE |
30 |
0.0015 |
| 193 |
CARBON DIOXIDE INCREASED |
2 |
0.0015 |
| 194 |
CORNEAL ABRASION |
2 |
0.0015 |
| 195 |
SINUSITIS |
148 |
0.0014 |
| 196 |
ENDOTRACHEAL INTUBATION |
4 |
0.0014 |
| 197 |
EYE CONTUSION |
3 |
0.0014 |
| 198 |
STAPHYLOCOCCAL SEPSIS |
7 |
0.0014 |
| 199 |
AUDITORY DISORDER |
2 |
0.0014 |
| 200 |
GRANULOCYTOPENIA |
8 |
0.0014 |
| 201 |
RESPIRATORY TRACT CONGESTION |
22 |
0.0014 |
| 202 |
DYSPNOEA AT REST |
4 |
0.0014 |
| 203 |
OLIGOMENORRHOEA |
3 |
0.0014 |
| 204 |
ACUTE ABDOMEN |
2 |
0.0014 |
| 205 |
SARS-COV-2 TEST POSITIVE |
18 |
0.0014 |
| 206 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
46 |
0.0014 |
| 207 |
POST PROCEDURAL INFECTION |
11 |
0.0014 |
| 208 |
BACTERAEMIA |
16 |
0.0013 |
| 209 |
INFECTIOUS MONONUCLEOSIS |
3 |
0.0013 |
| 210 |
WRONG PRODUCT ADMINISTERED |
9 |
0.0013 |
| 211 |
PRODUCT STORAGE ISSUE |
5 |
0.0013 |
| 212 |
EMERGENCY CARE |
4 |
0.0013 |
| 213 |
GASTRIC INFECTION |
5 |
0.0013 |
| 214 |
LOCALISED OEDEMA |
6 |
0.0013 |
| 215 |
RESPIRATORY TRACT INFECTION VIRAL |
3 |
0.0013 |
| 216 |
ORAL SURGERY |
3 |
0.0013 |
| 217 |
BACTERIAL VAGINOSIS |
2 |
0.0013 |
| 218 |
MUSCLE STRAIN |
11 |
0.0013 |
| 219 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
226 |
0.0013 |
| 220 |
TENDERNESS |
13 |
0.0012 |
| 221 |
DRUG EFFECT INCOMPLETE |
45 |
0.0012 |
| 222 |
ILLNESS |
127 |
0.0012 |
| 223 |
COSTOCHONDRITIS |
2 |
0.0012 |
| 224 |
DERMAL CYST |
3 |
0.0012 |
| 225 |
UPPER-AIRWAY COUGH SYNDROME |
10 |
0.0012 |
| 226 |
HYPERNATRAEMIA |
6 |
0.0012 |
| 227 |
DRUG DISPENSING ERROR |
18 |
0.0012 |
| 228 |
UPPER RESPIRATORY TRACT INFECTION |
54 |
0.0012 |
| 229 |
SKIN INFECTION |
13 |
0.0012 |
| 230 |
HORDEOLUM |
5 |
0.0012 |
| 231 |
TONSILLITIS |
6 |
0.0011 |
| 232 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
10 |
0.0011 |
| 233 |
PULMONARY FUNCTION TEST DECREASED |
5 |
0.0011 |
| 234 |
PRODUCT AVAILABILITY ISSUE |
26 |
0.0011 |
| 235 |
DYSPNOEA EXERTIONAL |
43 |
0.0011 |
| 236 |
INFUSION RELATED REACTION |
75 |
0.0011 |
| 237 |
LUNG TRANSPLANT |
4 |
0.0011 |
| 238 |
FOOD POISONING |
6 |
0.0011 |
| 239 |
CARDIAC ABLATION |
2 |
0.0011 |
| 240 |
WEIGHT INCREASED |
249 |
0.0011 |
| 241 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
19 |
0.0011 |
| 242 |
OROPHARYNGEAL DISCOMFORT |
10 |
0.0011 |
| 243 |
RED BLOOD CELL COUNT INCREASED |
3 |
0.0011 |
| 244 |
BODY TEMPERATURE ABNORMAL |
2 |
0.0011 |
| 245 |
CEREBROSPINAL FLUID LEAKAGE |
2 |
0.0011 |
| 246 |
ARTHRITIS INFECTIVE |
5 |
0.0011 |
| 247 |
EAR DISCOMFORT |
11 |
0.0011 |
| 248 |
EYE INFECTION |
12 |
0.0011 |
| 249 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
5 |
0.0011 |
| 250 |
CLAVICLE FRACTURE |
4 |
0.0010 |
| 251 |
FOOD ALLERGY |
8 |
0.0010 |
| 252 |
SKIN WARM |
6 |
0.0010 |
| 253 |
DEVICE POWER SOURCE ISSUE |
3 |
0.0010 |
| 254 |
HORMONE LEVEL ABNORMAL |
5 |
0.0010 |
| 255 |
AGRANULOCYTOSIS |
19 |
0.0010 |
| 256 |
VIRAL INFECTION |
34 |
0.0010 |
| 257 |
CANDIDA INFECTION |
17 |
0.0010 |
| 258 |
WHITE BLOOD CELL COUNT DECREASED |
109 |
0.0010 |
| 259 |
OBSTRUCTION |
4 |
0.0010 |
| 260 |
WRIST FRACTURE |
12 |
0.0010 |
| 261 |
LIMB INJURY |
27 |
0.0010 |
| 262 |
ENDOCARDITIS |
5 |
0.0010 |
| 263 |
ANAPHYLACTOID REACTION |
4 |
0.0010 |
| 264 |
DIASTOLIC DYSFUNCTION |
3 |
0.0010 |
| 265 |
KIDNEY INFECTION |
19 |
0.0010 |
| 266 |
PARTIAL SEIZURES |
5 |
0.0010 |
| 267 |
PRODUCT PACKAGING ISSUE |
9 |
0.0009 |
| 268 |
NEURALGIA |
23 |
0.0009 |
| 269 |
ARTHROPOD BITE |
7 |
0.0009 |
| 270 |
NO ADVERSE EVENT |
171 |
0.0009 |
| 271 |
FULL BLOOD COUNT DECREASED |
19 |
0.0009 |
| 272 |
LOSS OF THERAPEUTIC RESPONSE |
3 |
0.0009 |
| 273 |
PNEUMONIA VIRAL |
3 |
0.0009 |
| 274 |
SHOULDER OPERATION |
4 |
0.0009 |
| 275 |
HYSTERECTOMY |
8 |
0.0009 |
| 276 |
NASOPHARYNGITIS |
170 |
0.0009 |
| 277 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
0.0009 |
| 278 |
CHEST DISCOMFORT |
94 |
0.0009 |
| 279 |
BACTERIAL INFECTION |
17 |
0.0009 |
| 280 |
PRODUCT DOSE OMISSION ISSUE |
267 |
0.0009 |
| 281 |
ACCIDENT AT WORK |
2 |
0.0009 |
| 282 |
PHYSICAL DISABILITY |
4 |
0.0009 |
| 283 |
CONCUSSION |
7 |
0.0009 |
| 284 |
BACTERIAL TEST POSITIVE |
2 |
0.0009 |
| 285 |
SPINAL OPERATION |
11 |
0.0009 |
| 286 |
BLOOD LOSS ANAEMIA |
2 |
0.0009 |
| 287 |
DRUG EFFECT DELAYED |
4 |
0.0009 |
| 288 |
BODY TEMPERATURE INCREASED |
18 |
0.0009 |
| 289 |
ABDOMINAL DISTENSION |
92 |
0.0009 |
| 290 |
STAPHYLOCOCCAL INFECTION |
29 |
0.0009 |
| 291 |
INFLUENZA |
98 |
0.0009 |
| 292 |
EAR PAIN |
17 |
0.0009 |
| 293 |
LUMBAR VERTEBRAL FRACTURE |
4 |
0.0009 |
| 294 |
ONYCHOCLASIS |
6 |
0.0009 |
| 295 |
NASAL CONGESTION |
51 |
0.0009 |
| 296 |
COVID-19 |
152 |
0.0009 |
| 297 |
PRODUCTIVE COUGH |
41 |
0.0009 |
| 298 |
FLANK PAIN |
8 |
0.0009 |
| 299 |
TIBIA FRACTURE |
4 |
0.0009 |
| 300 |
THERMAL BURN |
6 |
0.0008 |
| 301 |
JOINT INJURY |
18 |
0.0008 |
| 302 |
PRODUCT SUPPLY ISSUE |
6 |
0.0008 |
| 303 |
CARDIAC PACEMAKER INSERTION |
5 |
0.0008 |
| 304 |
PROTHROMBIN TIME PROLONGED |
5 |
0.0008 |
| 305 |
WEIGHT DECREASED |
230 |
0.0008 |
| 306 |
PNEUMOTHORAX |
13 |
0.0008 |
| 307 |
SCAR |
14 |
0.0008 |
| 308 |
BREATH SOUNDS ABNORMAL |
4 |
0.0008 |
| 309 |
URINE OUTPUT DECREASED |
7 |
0.0008 |
| 310 |
RETCHING |
17 |
0.0008 |
| 311 |
BRAIN OEDEMA |
10 |
0.0008 |
| 312 |
FOOT FRACTURE |
15 |
0.0008 |
| 313 |
DERMATOMYOSITIS |
2 |
0.0008 |
| 314 |
APPENDICITIS PERFORATED |
2 |
0.0008 |
| 315 |
PARANASAL SINUS HYPERSECRETION |
3 |
0.0008 |
| 316 |
CHILLS |
92 |
0.0008 |
| 317 |
OESOPHAGEAL DISORDER |
3 |
0.0008 |
| 318 |
HAEMOLYSIS |
6 |
0.0008 |
| 319 |
SCRATCH |
8 |
0.0008 |
| 320 |
FURUNCLE |
6 |
0.0008 |
| 321 |
FUNGAL INFECTION |
25 |
0.0007 |
| 322 |
FUNGAL SKIN INFECTION |
3 |
0.0007 |
| 323 |
PRODUCT DOSE OMISSION IN ERROR |
21 |
0.0007 |
| 324 |
BLOOD SODIUM INCREASED |
2 |
0.0007 |
| 325 |
SKIN LACERATION |
8 |
0.0007 |
| 326 |
TACHYPNOEA |
10 |
0.0007 |
| 327 |
CLUMSINESS |
2 |
0.0007 |
| 328 |
CYSTITIS |
23 |
0.0007 |
| 329 |
RED CELL DISTRIBUTION WIDTH INCREASED |
3 |
0.0007 |
| 330 |
DIZZINESS POSTURAL |
7 |
0.0007 |
| 331 |
HEART RATE ABNORMAL |
4 |
0.0007 |
| 332 |
THERAPY CHANGE |
7 |
0.0007 |
| 333 |
MUSCLE FATIGUE |
3 |
0.0007 |
| 334 |
SINUS DISORDER |
14 |
0.0007 |
| 335 |
PAIN IN JAW |
20 |
0.0007 |
| 336 |
PYREXIA |
244 |
0.0007 |
| 337 |
DIALYSIS |
10 |
0.0007 |
| 338 |
LOCALISED INFECTION |
17 |
0.0007 |
| 339 |
PURULENT DISCHARGE |
3 |
0.0007 |
| 340 |
PALLOR |
19 |
0.0007 |
| 341 |
EXERCISE TOLERANCE DECREASED |
4 |
0.0007 |
| 342 |
LIGAMENT RUPTURE |
3 |
0.0007 |
| 343 |
SENSITIVE SKIN |
5 |
0.0007 |
| 344 |
CATHETERISATION CARDIAC |
3 |
0.0007 |
| 345 |
SINUS HEADACHE |
4 |
0.0007 |
| 346 |
ANAPHYLACTIC REACTION |
37 |
0.0007 |
| 347 |
BRAIN HERNIATION |
2 |
0.0007 |
| 348 |
ATYPICAL PNEUMONIA |
2 |
0.0007 |
| 349 |
SYMPTOM RECURRENCE |
4 |
0.0007 |
| 350 |
BLOOD CULTURE POSITIVE |
2 |
0.0007 |
| 351 |
HEART RATE INCREASED |
66 |
0.0007 |
| 352 |
THROAT TIGHTNESS |
18 |
0.0007 |
| 353 |
CONTUSION |
64 |
0.0007 |
| 354 |
SUSPECTED OFF LABEL USE |
3 |
0.0007 |
| 355 |
OSTEOMYELITIS |
12 |
0.0007 |
| 356 |
ABDOMINAL HERNIA |
3 |
0.0007 |
| 357 |
BRONCHITIS |
48 |
0.0006 |
| 358 |
INTERCEPTED MEDICATION ERROR |
3 |
0.0006 |
| 359 |
FEELING COLD |
18 |
0.0006 |
| 360 |
PHARYNGITIS |
8 |
0.0006 |
| 361 |
BURNING SENSATION |
45 |
0.0006 |
| 362 |
WHEEZING |
38 |
0.0006 |
| 363 |
BLOOD BLISTER |
2 |
0.0006 |
| 364 |
DEVICE OCCLUSION |
9 |
0.0006 |
| 365 |
BRAIN FOG |
10 |
0.0006 |
| 366 |
GASTROINTESTINAL PAIN |
7 |
0.0006 |
| 367 |
TOOTH FRACTURE |
7 |
0.0006 |
| 368 |
PRODUCT USE COMPLAINT |
10 |
0.0006 |
| 369 |
BREAST CANCER RECURRENT |
2 |
0.0006 |
| 370 |
BLADDER PAIN |
2 |
0.0006 |
| 371 |
LIMB OPERATION |
3 |
0.0006 |
| 372 |
POST PROCEDURAL COMPLICATION |
12 |
0.0006 |
| 373 |
COLD SWEAT |
11 |
0.0006 |
| 374 |
COUGH |
174 |
0.0006 |
| 375 |
MYASTHENIA GRAVIS |
5 |
0.0006 |
| 376 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
44 |
0.0006 |
| 377 |
HOSPITALISATION |
95 |
0.0006 |
| 378 |
THROMBOSIS |
49 |
0.0006 |
| 379 |
ESCHERICHIA INFECTION |
5 |
0.0006 |
| 380 |
HYPERVOLAEMIA |
3 |
0.0006 |
| 381 |
TOOTH INFECTION |
8 |
0.0006 |
| 382 |
PRODUCT FORMULATION ISSUE |
4 |
0.0006 |
| 383 |
FOOT OPERATION |
3 |
0.0006 |
| 384 |
CORONAVIRUS INFECTION |
4 |
0.0006 |
| 385 |
ANEURYSM |
3 |
0.0006 |
| 386 |
INJECTION SITE INFLAMMATION |
3 |
0.0006 |
| 387 |
PROTEIN URINE PRESENT |
3 |
0.0006 |
| 388 |
PREGNANCY |
12 |
0.0006 |
| 389 |
PRODUCT PRESCRIBING ISSUE |
13 |
0.0006 |
| 390 |
INTENTIONAL DOSE OMISSION |
17 |
0.0006 |
| 391 |
EXPOSURE DURING PREGNANCY |
37 |
0.0006 |
| 392 |
PRODUCT ADMINISTRATION ERROR |
12 |
0.0006 |
| 393 |
POSTOPERATIVE WOUND INFECTION |
4 |
0.0006 |
| 394 |
PRODUCT USE ISSUE |
111 |
0.0006 |
| 395 |
RHINORRHOEA |
38 |
0.0006 |
| 396 |
SWELLING |
55 |
0.0006 |
| 397 |
INFECTION |
85 |
0.0006 |
| 398 |
GINGIVAL BLEEDING |
8 |
0.0006 |
| 399 |
TEMPERATURE INTOLERANCE |
6 |
0.0006 |
| 400 |
SNEEZING |
13 |
0.0006 |
| 401 |
MIGRAINE |
55 |
0.0006 |
| 402 |
SKIN SWELLING |
5 |
0.0006 |
| 403 |
ROAD TRAFFIC ACCIDENT |
24 |
0.0006 |
| 404 |
MASS |
8 |
0.0006 |
| 405 |
MATERNAL EXPOSURE DURING PREGNANCY |
51 |
0.0006 |
| 406 |
INJECTION SITE DISCOMFORT |
6 |
0.0006 |
| 407 |
RESPIRATORY DISORDER |
17 |
0.0006 |
| 408 |
PAPULE |
4 |
0.0006 |
| 409 |
TOOTH EXTRACTION |
7 |
0.0006 |
| 410 |
APPENDICECTOMY |
2 |
0.0006 |
| 411 |
GASTROINTESTINAL DISORDER |
50 |
0.0006 |
| 412 |
MEDICATION ERROR |
31 |
0.0006 |
| 413 |
IMPAIRED QUALITY OF LIFE |
8 |
0.0006 |
| 414 |
ANAL INCONTINENCE |
5 |
0.0006 |
| 415 |
HIP SURGERY |
3 |
0.0006 |
| 416 |
PLATELET COUNT DECREASED |
59 |
0.0006 |
| 417 |
BLOOD PRESSURE ABNORMAL |
11 |
0.0006 |
| 418 |
PULMONARY THROMBOSIS |
6 |
0.0005 |
| 419 |
INJECTION SITE IRRITATION |
7 |
0.0005 |
| 420 |
OROPHARYNGEAL PAIN |
50 |
0.0005 |
| 421 |
DIPLOPIA |
14 |
0.0005 |
| 422 |
NECROSIS |
3 |
0.0005 |
| 423 |
CARDIAC DYSFUNCTION |
2 |
0.0005 |
| 424 |
APPENDICITIS |
5 |
0.0005 |
| 425 |
ANGIOPATHY |
3 |
0.0005 |
| 426 |
PERIORBITAL SWELLING |
3 |
0.0005 |
| 427 |
ADVERSE REACTION |
7 |
0.0005 |
| 428 |
SPUTUM DISCOLOURED |
5 |
0.0005 |
| 429 |
NEPHROLITHIASIS |
24 |
0.0005 |
| 430 |
ELECTROLYTE IMBALANCE |
6 |
0.0005 |
| 431 |
URINARY TRACT INFECTION |
87 |
0.0005 |
| 432 |
HEPATIC FUNCTION ABNORMAL |
19 |
0.0005 |
| 433 |
HEAD DISCOMFORT |
9 |
0.0005 |
| 434 |
BLOOD IRON DECREASED |
6 |
0.0005 |
| 435 |
ANAPHYLACTIC SHOCK |
13 |
0.0005 |
| 436 |
UPPER LIMB FRACTURE |
10 |
0.0005 |
| 437 |
SCIATICA |
8 |
0.0005 |
| 438 |
OVARIAN CYST |
5 |
0.0005 |
| 439 |
CYSTITIS HAEMORRHAGIC |
2 |
0.0005 |
| 440 |
RHINITIS |
4 |
0.0005 |
| 441 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
3 |
0.0005 |
| 442 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
27 |
0.0005 |
| 443 |
DISCOMFORT |
30 |
0.0005 |
| 444 |
TOOTH ABSCESS |
5 |
0.0005 |
| 445 |
POLYURIA |
4 |
0.0005 |
| 446 |
TRANSFUSION |
5 |
0.0005 |
| 447 |
BLEPHAROSPASM |
3 |
0.0005 |
| 448 |
IMMUNODEFICIENCY |
7 |
0.0005 |
| 449 |
DIVERTICULITIS |
13 |
0.0005 |
| 450 |
ABDOMINAL PAIN |
109 |
0.0005 |
| 451 |
DEVICE ISSUE |
42 |
0.0005 |
| 452 |
PRODUCT USE IN UNAPPROVED INDICATION |
116 |
0.0005 |
| 453 |
UNRESPONSIVE TO STIMULI |
12 |
0.0005 |
| 454 |
NAIL DISORDER |
4 |
0.0005 |
| 455 |
TINNITUS |
21 |
0.0005 |
| 456 |
ORAL CANDIDIASIS |
6 |
0.0005 |
| 457 |
GROIN PAIN |
4 |
0.0005 |
| 458 |
PRODUCT COMMUNICATION ISSUE |
4 |
0.0005 |
| 459 |
EXPIRED PRODUCT ADMINISTERED |
15 |
0.0005 |
| 460 |
OBSTRUCTIVE AIRWAYS DISORDER |
5 |
0.0004 |
| 461 |
BREAST MASS |
3 |
0.0004 |
| 462 |
NEPHROPATHY TOXIC |
5 |
0.0004 |
| 463 |
BLOOD PRESSURE INCREASED |
68 |
0.0004 |
| 464 |
FALL |
148 |
0.0004 |
| 465 |
HEAD INJURY |
14 |
0.0004 |
| 466 |
VOMITING |
207 |
0.0004 |
| 467 |
ABNORMAL LOSS OF WEIGHT |
3 |
0.0004 |
| 468 |
ULCER |
7 |
0.0004 |
| 469 |
BLOOD PRESSURE DECREASED |
29 |
0.0004 |
| 470 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
4 |
0.0004 |
| 471 |
BLOOD PRESSURE DIASTOLIC INCREASED |
2 |
0.0004 |
| 472 |
HEADACHE |
271 |
0.0004 |
| 473 |
CONJUNCTIVITIS |
8 |
0.0004 |
| 474 |
LACRIMATION INCREASED |
13 |
0.0004 |
| 475 |
SPLENOMEGALY |
5 |
0.0004 |
| 476 |
THROAT IRRITATION |
19 |
0.0004 |
| 477 |
PNEUMONIA |
137 |
0.0004 |
| 478 |
DRUG LEVEL INCREASED |
7 |
0.0004 |
| 479 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
3 |
0.0004 |
| 480 |
RASH ERYTHEMATOUS |
20 |
0.0004 |
| 481 |
CELLULITIS |
21 |
0.0004 |
| 482 |
SWOLLEN TONGUE |
13 |
0.0004 |
| 483 |
CHEST PAIN |
77 |
0.0004 |
| 484 |
VISUAL FIELD DEFECT |
3 |
0.0004 |
| 485 |
HERNIA |
8 |
0.0004 |
| 486 |
MOUTH HAEMORRHAGE |
3 |
0.0004 |
| 487 |
PHARYNGEAL SWELLING |
4 |
0.0004 |
| 488 |
FEELING HOT |
25 |
0.0004 |
| 489 |
HEPATOMEGALY |
4 |
0.0004 |
| 490 |
INABILITY TO AFFORD MEDICATION |
4 |
0.0004 |
| 491 |
HYDRONEPHROSIS |
3 |
0.0004 |
| 492 |
HYPOTONIA |
4 |
0.0004 |
| 493 |
LEUKOPENIA |
20 |
0.0004 |
| 494 |
SECRETION DISCHARGE |
5 |
0.0004 |
| 495 |
HYPOAESTHESIA ORAL |
6 |
0.0004 |
| 496 |
DERMATITIS ALLERGIC |
5 |
0.0004 |
| 497 |
HYPOACUSIS |
17 |
0.0004 |
| 498 |
SEPSIS |
44 |
0.0004 |
| 499 |
FEEDING DISORDER |
8 |
0.0004 |
| 500 |
HYPERSENSITIVITY |
73 |
0.0004 |
| 501 |
SLUGGISHNESS |
4 |
0.0004 |
| 502 |
HIP ARTHROPLASTY |
6 |
0.0004 |
| 503 |
DEVICE PHYSICAL PROPERTY ISSUE |
3 |
0.0004 |
| 504 |
OXYGEN SATURATION DECREASED |
22 |
0.0004 |
| 505 |
HYPERBILIRUBINAEMIA |
4 |
0.0004 |
| 506 |
PRODUCT ADMINISTRATION INTERRUPTED |
3 |
0.0004 |
| 507 |
URTICARIA |
64 |
0.0004 |
| 508 |
AFFECTIVE DISORDER |
3 |
0.0004 |
| 509 |
CYANOSIS |
6 |
0.0004 |
| 510 |
MUSCLE SPASMS |
70 |
0.0004 |
| 511 |
HAEMATURIA |
13 |
0.0004 |
| 512 |
PULMONARY CONGESTION |
5 |
0.0004 |
| 513 |
NASAL DISCOMFORT |
3 |
0.0004 |
| 514 |
JOINT DISLOCATION |
4 |
0.0004 |
| 515 |
VERTIGO |
23 |
0.0004 |
| 516 |
EYE HAEMORRHAGE |
5 |
0.0004 |
| 517 |
FRUSTRATION TOLERANCE DECREASED |
3 |
0.0004 |
| 518 |
HEART RATE DECREASED |
13 |
0.0004 |
| 519 |
BEHAVIOUR DISORDER |
2 |
0.0004 |
| 520 |
BLOOD POTASSIUM INCREASED |
6 |
0.0004 |
| 521 |
PRODUCT QUALITY ISSUE |
50 |
0.0004 |
| 522 |
BACK INJURY |
4 |
0.0004 |
| 523 |
FATIGUE |
286 |
0.0004 |
| 524 |
INJECTION SITE URTICARIA |
9 |
0.0004 |
| 525 |
LIVER INJURY |
9 |
0.0004 |
| 526 |
ABNORMAL FAECES |
3 |
0.0004 |
| 527 |
INTERVERTEBRAL DISC PROTRUSION |
8 |
0.0004 |
| 528 |
BLOOD POTASSIUM DECREASED |
11 |
0.0004 |
| 529 |
MENSTRUAL DISORDER |
3 |
0.0004 |
| 530 |
EMBOLISM |
3 |
0.0004 |
| 531 |
PAIN |
221 |
0.0004 |
| 532 |
BLOOD PRESSURE SYSTOLIC INCREASED |
7 |
0.0004 |
| 533 |
BLOOD UREA INCREASED |
6 |
0.0004 |
| 534 |
HAEMODIALYSIS |
3 |
0.0004 |
| 535 |
PAIN IN EXTREMITY |
105 |
0.0004 |
| 536 |
OCULAR DISCOMFORT |
4 |
0.0004 |
| 537 |
SENSATION OF FOREIGN BODY |
3 |
0.0004 |
| 538 |
FISTULA |
4 |
0.0004 |
| 539 |
LIMB DISCOMFORT |
11 |
0.0004 |
| 540 |
SEIZURE |
41 |
0.0004 |
| 541 |
HEART RATE IRREGULAR |
8 |
0.0004 |
| 542 |
SINUS TACHYCARDIA |
5 |
0.0004 |
| 543 |
DRUG-INDUCED LIVER INJURY |
11 |
0.0004 |
| 544 |
ERYTHEMA |
72 |
0.0003 |
| 545 |
MICTURITION URGENCY |
4 |
0.0003 |
| 546 |
INTERNAL HAEMORRHAGE |
4 |
0.0003 |
| 547 |
PSEUDOMONAS INFECTION |
3 |
0.0003 |
| 548 |
SYNCOPE |
35 |
0.0003 |
| 549 |
HYPERSOMNIA |
10 |
0.0003 |
| 550 |
NAUSEA |
275 |
0.0003 |
| 551 |
CONDITION AGGRAVATED |
105 |
0.0003 |
| 552 |
PULMONARY ARTERIAL HYPERTENSION |
5 |
0.0003 |
| 553 |
HYPERTENSION |
73 |
0.0003 |
| 554 |
FLUSHING |
35 |
0.0003 |
| 555 |
RASH MACULAR |
12 |
0.0003 |
| 556 |
BLOOD TRIGLYCERIDES INCREASED |
6 |
0.0003 |
| 557 |
DRUG EFFECT LESS THAN EXPECTED |
5 |
0.0003 |
| 558 |
INCORRECT DOSE ADMINISTERED |
77 |
0.0003 |
| 559 |
FACIAL PAIN |
3 |
0.0003 |
| 560 |
INJECTION SITE PAIN |
103 |
0.0003 |
| 561 |
ACCIDENT |
4 |
0.0003 |
| 562 |
MYOSITIS |
3 |
0.0003 |
| 563 |
PALPITATIONS |
39 |
0.0003 |
| 564 |
KNEE ARTHROPLASTY |
7 |
0.0003 |
| 565 |
OEDEMA |
18 |
0.0003 |
| 566 |
HERPES ZOSTER |
19 |
0.0003 |
| 567 |
UNEVALUABLE EVENT |
25 |
0.0003 |
| 568 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
12 |
0.0003 |
| 569 |
LETHARGY |
19 |
0.0003 |
| 570 |
EATING DISORDER |
7 |
0.0003 |
| 571 |
EYE PRURITUS |
11 |
0.0003 |
| 572 |
PNEUMONIA BACTERIAL |
3 |
0.0003 |
| 573 |
DYSPNOEA |
185 |
0.0003 |
| 574 |
CYTOPENIA |
4 |
0.0003 |
| 575 |
DYSURIA |
12 |
0.0003 |
| 576 |
INJECTION SITE RASH |
10 |
0.0003 |
| 577 |
SKIN CANCER |
7 |
0.0003 |
| 578 |
NERVE COMPRESSION |
3 |
0.0003 |
| 579 |
INTERCEPTED PRODUCT PREPARATION ERROR |
4 |
0.0003 |
| 580 |
PROCEDURAL PAIN |
9 |
0.0003 |
| 581 |
SURGERY |
19 |
0.0003 |
| 582 |
CONCOMITANT DISEASE AGGRAVATED |
2 |
0.0003 |
| 583 |
HYPERCALCAEMIA |
4 |
0.0003 |
| 584 |
ANKLE FRACTURE |
5 |
0.0003 |
| 585 |
BACK PAIN |
75 |
0.0003 |
| 586 |
HAEMOPTYSIS |
9 |
0.0003 |
| 587 |
RENAL DISORDER |
15 |
0.0003 |
| 588 |
MENTAL DISORDER |
14 |
0.0003 |
| 589 |
BRADYCARDIA |
17 |
0.0003 |
| 590 |
DYSARTHRIA |
12 |
0.0003 |
| 591 |
BLOOD SODIUM DECREASED |
6 |
0.0003 |
| 592 |
ABDOMINAL DISCOMFORT |
53 |
0.0003 |
| 593 |
SUPRAVENTRICULAR TACHYCARDIA |
3 |
0.0003 |
| 594 |
CHOLESTASIS |
6 |
0.0003 |
| 595 |
LOWER LIMB FRACTURE |
6 |
0.0003 |
| 596 |
CARDIAC FLUTTER |
2 |
0.0003 |
| 597 |
HIATUS HERNIA |
4 |
0.0003 |
| 598 |
MUSCLE TIGHTNESS |
5 |
0.0003 |
| 599 |
ORAL HERPES |
6 |
0.0003 |
| 600 |
VITREOUS FLOATERS |
3 |
0.0003 |
| 601 |
KNEE OPERATION |
3 |
0.0003 |
| 602 |
DIZZINESS |
152 |
0.0003 |
| 603 |
BODY TEMPERATURE DECREASED |
3 |
0.0003 |
| 604 |
ASPERGILLUS INFECTION |
2 |
0.0003 |
| 605 |
LOSS OF CONSCIOUSNESS |
39 |
0.0003 |
| 606 |
PERICARDIAL EFFUSION |
7 |
0.0003 |
| 607 |
POOR QUALITY DEVICE USED |
3 |
0.0003 |
| 608 |
MALIGNANT MELANOMA |
4 |
0.0003 |
| 609 |
QUALITY OF LIFE DECREASED |
4 |
0.0003 |
| 610 |
PERICARDITIS |
5 |
0.0003 |
| 611 |
HYPOTHERMIA |
3 |
0.0003 |
| 612 |
TREMOR |
49 |
0.0003 |
| 613 |
RASH PRURITIC |
16 |
0.0003 |
| 614 |
OCULAR HYPERAEMIA |
14 |
0.0003 |
| 615 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
5 |
0.0003 |
| 616 |
MALAISE |
129 |
0.0003 |
| 617 |
EPISTAXIS |
22 |
0.0003 |
| 618 |
THERAPY INTERRUPTED |
21 |
0.0003 |
| 619 |
HEPATIC ENZYME INCREASED |
20 |
0.0003 |
| 620 |
BLOOD TESTOSTERONE DECREASED |
2 |
0.0003 |
| 621 |
SKIN LESION |
8 |
0.0003 |
| 622 |
COLITIS |
11 |
0.0003 |
| 623 |
EYE DISCHARGE |
3 |
0.0003 |
| 624 |
PULMONARY HYPERTENSION |
6 |
0.0003 |
| 625 |
PRESYNCOPE |
7 |
0.0003 |
| 626 |
PETECHIAE |
3 |
0.0003 |
| 627 |
PRODUCT ODOUR ABNORMAL |
3 |
0.0003 |
| 628 |
CARPAL TUNNEL SYNDROME |
4 |
0.0003 |
| 629 |
PERIPHERAL SWELLING |
44 |
0.0003 |
| 630 |
PRODUCT STORAGE ERROR |
25 |
0.0003 |
| 631 |
NEUROPATHY PERIPHERAL |
27 |
0.0003 |
| 632 |
EYE PAIN |
16 |
0.0003 |
| 633 |
RENAL PAIN |
3 |
0.0003 |
| 634 |
LYMPHADENOPATHY |
10 |
0.0003 |
| 635 |
TACHYCARDIA |
25 |
0.0003 |
| 636 |
LIVER FUNCTION TEST INCREASED |
6 |
0.0003 |
| 637 |
POOR QUALITY SLEEP |
6 |
0.0003 |
| 638 |
PRURITUS |
107 |
0.0003 |
| 639 |
CARDIAC DISORDER |
26 |
0.0003 |
| 640 |
DEHYDRATION |
37 |
0.0003 |
| 641 |
PARAESTHESIA ORAL |
4 |
0.0003 |
| 642 |
ASTHENIA |
104 |
0.0003 |
| 643 |
FLUID RETENTION |
14 |
0.0003 |
| 644 |
RESTLESS LEGS SYNDROME |
5 |
0.0003 |
| 645 |
CLOSTRIDIUM DIFFICILE INFECTION |
6 |
0.0003 |
| 646 |
NEEDLE ISSUE |
8 |
0.0003 |
| 647 |
RESPIRATORY FAILURE |
20 |
0.0003 |
| 648 |
GASTROENTERITIS |
4 |
0.0003 |
| 649 |
ASPIRATION |
3 |
0.0003 |
| 650 |
ABDOMINAL PAIN UPPER |
56 |
0.0003 |
| 651 |
ARTHRALGIA |
113 |
0.0003 |
| 652 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
| 653 |
MYALGIA |
46 |
0.0003 |
| 654 |
EXPOSURE VIA SKIN CONTACT |
7 |
0.0003 |
| 655 |
TOOTH DISORDER |
6 |
0.0003 |
| 656 |
NERVE INJURY |
3 |
0.0003 |
| 657 |
INTESTINAL OBSTRUCTION |
10 |
0.0003 |
| 658 |
LUNG DISORDER |
13 |
0.0003 |
| 659 |
PANCREATITIS |
14 |
0.0003 |
| 660 |
LOWER RESPIRATORY TRACT INFECTION |
12 |
0.0003 |
| 661 |
SCAB |
3 |
0.0003 |
| 662 |
PROTEINURIA |
5 |
0.0003 |
| 663 |
INJECTION SITE REACTION |
18 |
0.0003 |
| 664 |
BOWEL MOVEMENT IRREGULARITY |
2 |
0.0003 |
| 665 |
SKIN DISCOLOURATION |
12 |
0.0003 |
| 666 |
SWELLING FACE |
17 |
0.0003 |
| 667 |
NEOPLASM |
3 |
0.0003 |
| 668 |
ACUTE RESPIRATORY FAILURE |
5 |
0.0003 |
| 669 |
LUNG INFECTION |
4 |
0.0003 |
| 670 |
DIARRHOEA |
166 |
0.0003 |
| 671 |
ARTHRITIS |
20 |
0.0003 |
| 672 |
COVID-19 PNEUMONIA |
3 |
0.0003 |
| 673 |
HYPOAESTHESIA |
38 |
0.0003 |
| 674 |
DEVICE DISLOCATION |
11 |
0.0003 |
| 675 |
WOUND |
7 |
0.0003 |
| 676 |
PRODUCT PHYSICAL ISSUE |
5 |
0.0002 |
| 677 |
TASTE DISORDER |
5 |
0.0002 |
| 678 |
MUSCULAR WEAKNESS |
28 |
0.0002 |
| 679 |
COLITIS ULCERATIVE |
11 |
0.0002 |
| 680 |
BACK DISORDER |
4 |
0.0002 |
| 681 |
DECUBITUS ULCER |
2 |
0.0002 |
| 682 |
RIB FRACTURE |
5 |
0.0002 |
| 683 |
INJECTION SITE WARMTH |
5 |
0.0002 |
| 684 |
PHOTOSENSITIVITY REACTION |
4 |
0.0002 |
| 685 |
EYE SWELLING |
9 |
0.0002 |
| 686 |
CYST |
3 |
0.0002 |
| 687 |
PSYCHOMOTOR HYPERACTIVITY |
4 |
0.0002 |
| 688 |
SLEEP DISORDER |
17 |
0.0002 |
| 689 |
DRY EYE |
12 |
0.0002 |
| 690 |
PNEUMONIA ASPIRATION |
6 |
0.0002 |
| 691 |
COAGULOPATHY |
4 |
0.0002 |
| 692 |
ANXIETY |
68 |
0.0002 |
| 693 |
INJECTION SITE PRURITUS |
16 |
0.0002 |
| 694 |
RASH |
104 |
0.0002 |
| 695 |
ASCITES |
7 |
0.0002 |
| 696 |
MOUTH ULCERATION |
5 |
0.0002 |
| 697 |
HAEMATEMESIS |
6 |
0.0002 |
| 698 |
CARDIAC FAILURE CONGESTIVE |
19 |
0.0002 |
| 699 |
URINARY INCONTINENCE |
7 |
0.0002 |
| 700 |
HEMIPARESIS |
4 |
0.0002 |
| 701 |
CARDIAC OPERATION |
2 |
0.0002 |
| 702 |
MUSCULOSKELETAL DISCOMFORT |
4 |
0.0002 |
| 703 |
ANURIA |
2 |
0.0002 |
| 704 |
JOINT SWELLING |
28 |
0.0002 |
| 705 |
BLOOD MAGNESIUM DECREASED |
2 |
0.0002 |
| 706 |
PLATELET COUNT INCREASED |
3 |
0.0002 |
| 707 |
NODULE |
3 |
0.0002 |
| 708 |
BLOOD CREATININE INCREASED |
15 |
0.0002 |
| 709 |
FEELING ABNORMAL |
55 |
0.0002 |
| 710 |
PARAESTHESIA |
36 |
0.0002 |
| 711 |
DEVICE USE ISSUE |
4 |
0.0002 |
| 712 |
INCORRECT PRODUCT STORAGE |
3 |
0.0002 |
| 713 |
BLOOD CALCIUM INCREASED |
2 |
0.0002 |
| 714 |
GASTRITIS |
6 |
0.0002 |
| 715 |
ANGIOEDEMA |
10 |
0.0002 |
| 716 |
GALLBLADDER DISORDER |
4 |
0.0002 |
| 717 |
CEREBRAL HAEMORRHAGE |
8 |
0.0002 |
| 718 |
RASH PAPULAR |
5 |
0.0002 |
| 719 |
DEVELOPMENTAL DELAY |
2 |
0.0002 |
| 720 |
OEDEMA PERIPHERAL |
27 |
0.0002 |
| 721 |
LEUKOCYTOSIS |
4 |
0.0002 |
| 722 |
DRUG TOXICITY |
3 |
0.0002 |
| 723 |
CRYING |
8 |
0.0002 |
| 724 |
HYPERGLYCAEMIA |
8 |
0.0002 |
| 725 |
VISION BLURRED |
30 |
0.0002 |
| 726 |
RESPIRATORY ARREST |
6 |
0.0002 |
| 727 |
RESPIRATORY DISTRESS |
6 |
0.0002 |
| 728 |
MUSCLE TWITCHING |
5 |
0.0002 |
| 729 |
POLLAKIURIA |
9 |
0.0002 |
| 730 |
HUNGER |
3 |
0.0002 |
| 731 |
APHONIA |
3 |
0.0002 |
| 732 |
NECK PAIN |
12 |
0.0002 |
| 733 |
HAEMOGLOBIN DECREASED |
22 |
0.0002 |
| 734 |
SKIN REACTION |
3 |
0.0002 |
| 735 |
PHOTOPHOBIA |
4 |
0.0002 |
| 736 |
ASTHMA |
24 |
0.0002 |
| 737 |
ADVERSE DRUG REACTION |
19 |
0.0002 |
| 738 |
DYSPHAGIA |
20 |
0.0002 |
| 739 |
BLOOD URINE PRESENT |
4 |
0.0002 |
| 740 |
HAEMORRHAGE |
22 |
0.0002 |
| 741 |
RED BLOOD CELL COUNT DECREASED |
6 |
0.0002 |
| 742 |
HYPERHIDROSIS |
27 |
0.0002 |
| 743 |
INJECTION SITE SWELLING |
16 |
0.0002 |
| 744 |
EYE IRRITATION |
12 |
0.0002 |
| 745 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
10 |
0.0002 |
| 746 |
AFFECT LABILITY |
2 |
0.0002 |
| 747 |
TRANSIENT ISCHAEMIC ATTACK |
7 |
0.0002 |
| 748 |
ATELECTASIS |
2 |
0.0002 |
| 749 |
ADVERSE EVENT |
19 |
0.0002 |
| 750 |
ATRIAL FIBRILLATION |
20 |
0.0002 |
| 751 |
AUTOIMMUNE DISORDER |
2 |
0.0002 |
| 752 |
DYSPHONIA |
12 |
0.0002 |
| 753 |
HAEMORRHOIDS |
4 |
0.0002 |
| 754 |
CHOKING |
4 |
0.0002 |
| 755 |
HYPOTENSION |
41 |
0.0002 |
| 756 |
GASTRIC DISORDER |
7 |
0.0002 |
| 757 |
COELIAC DISEASE |
2 |
0.0002 |
| 758 |
DYSPEPSIA |
20 |
0.0002 |
| 759 |
SKIN HAEMORRHAGE |
3 |
0.0002 |
| 760 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
8 |
0.0002 |
| 761 |
HAEMATOCRIT DECREASED |
4 |
0.0002 |
| 762 |
INJECTION SITE ERYTHEMA |
25 |
0.0002 |
| 763 |
BLADDER DISORDER |
2 |
0.0002 |
| 764 |
PULMONARY MASS |
3 |
0.0002 |
| 765 |
HAEMORRHAGE INTRACRANIAL |
3 |
0.0002 |
| 766 |
HEPATIC FAILURE |
6 |
0.0002 |
| 767 |
PROSTATE CANCER |
16 |
0.0002 |
| 768 |
HYPOXIA |
7 |
0.0002 |
| 769 |
APHASIA |
6 |
0.0002 |
| 770 |
ECONOMIC PROBLEM |
3 |
0.0002 |
| 771 |
ARTHROPATHY |
11 |
0.0002 |
| 772 |
TOXIC EPIDERMAL NECROLYSIS |
3 |
0.0002 |
| 773 |
OFF LABEL USE |
172 |
0.0002 |
| 774 |
ALANINE AMINOTRANSFERASE INCREASED |
12 |
0.0002 |
| 775 |
INFLUENZA LIKE ILLNESS |
16 |
0.0002 |
| 776 |
ANAEMIA |
37 |
0.0002 |
| 777 |
FLATULENCE |
11 |
0.0002 |
| 778 |
MUSCULOSKELETAL CHEST PAIN |
3 |
0.0002 |
| 779 |
INFLAMMATION |
10 |
0.0002 |
| 780 |
EJECTION FRACTION DECREASED |
3 |
0.0002 |
| 781 |
NERVOUS SYSTEM DISORDER |
6 |
0.0002 |
| 782 |
SPEECH DISORDER |
10 |
0.0002 |
| 783 |
ARRHYTHMIA |
9 |
0.0002 |
| 784 |
INJECTION SITE MASS |
7 |
0.0002 |
| 785 |
DEPRESSED MOOD |
10 |
0.0002 |
| 786 |
OBESITY |
3 |
0.0002 |
| 787 |
ABSCESS |
3 |
0.0002 |
| 788 |
SENSORY DISTURBANCE |
3 |
0.0002 |
| 789 |
GASTROOESOPHAGEAL REFLUX DISEASE |
15 |
0.0002 |
| 790 |
BREAST CANCER METASTATIC |
2 |
0.0002 |
| 791 |
INJURY |
13 |
0.0002 |
| 792 |
WHITE BLOOD CELL COUNT INCREASED |
7 |
0.0002 |
| 793 |
ILL-DEFINED DISORDER |
11 |
0.0002 |
| 794 |
DECREASED APPETITE |
42 |
0.0002 |
| 795 |
NEOPLASM MALIGNANT |
12 |
0.0002 |
| 796 |
GAIT INABILITY |
6 |
0.0002 |
| 797 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0002 |
| 798 |
FACE OEDEMA |
3 |
0.0002 |
| 799 |
CHROMATURIA |
4 |
0.0002 |
| 800 |
SKIN IRRITATION |
8 |
0.0002 |
| 801 |
EXTRA DOSE ADMINISTERED |
7 |
0.0002 |
| 802 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
9 |
0.0002 |
| 803 |
LOCAL SWELLING |
3 |
0.0002 |
| 804 |
LIVER FUNCTION TEST ABNORMAL |
5 |
0.0002 |
| 805 |
CAESAREAN SECTION |
2 |
0.0002 |
| 806 |
MUSCULOSKELETAL STIFFNESS |
15 |
0.0002 |
| 807 |
DERMATITIS ATOPIC |
9 |
0.0002 |
| 808 |
LYMPHOCYTE COUNT DECREASED |
3 |
0.0002 |
| 809 |
CARDIAC ARREST |
14 |
0.0002 |
| 810 |
ACUTE MYOCARDIAL INFARCTION |
5 |
0.0002 |
| 811 |
ASPARTATE AMINOTRANSFERASE INCREASED |
9 |
0.0002 |
| 812 |
PSYCHOTIC DISORDER |
5 |
0.0002 |
| 813 |
DRUG ERUPTION |
3 |
0.0002 |
| 814 |
PRODUCT PRESCRIBING ERROR |
4 |
0.0002 |
| 815 |
GOUT |
3 |
0.0002 |
| 816 |
BLOOD PRESSURE FLUCTUATION |
4 |
0.0002 |
| 817 |
TOOTHACHE |
3 |
0.0002 |
| 818 |
MENTAL IMPAIRMENT |
4 |
0.0002 |
| 819 |
BURSITIS |
2 |
0.0002 |
| 820 |
END STAGE RENAL DISEASE |
3 |
0.0002 |
| 821 |
SOMNOLENCE |
33 |
0.0002 |
| 822 |
RECTAL HAEMORRHAGE |
7 |
0.0002 |
| 823 |
CARDIOMEGALY |
2 |
0.0002 |
| 824 |
ABNORMAL WEIGHT GAIN |
2 |
0.0002 |
| 825 |
SEPTIC SHOCK |
7 |
0.0002 |
| 826 |
BLISTER |
9 |
0.0002 |
| 827 |
BLOOD GLUCOSE INCREASED |
30 |
0.0002 |
| 828 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
4 |
0.0002 |
| 829 |
GASTRIC ULCER |
3 |
0.0002 |
| 830 |
SLEEP APNOEA SYNDROME |
3 |
0.0002 |
| 831 |
HYPOPHAGIA |
4 |
0.0002 |
| 832 |
THERAPY CESSATION |
8 |
0.0002 |
| 833 |
GENERAL PHYSICAL HEALTH DETERIORATION |
18 |
0.0002 |
| 834 |
ERUCTATION |
3 |
0.0002 |
| 835 |
DYSTONIA |
3 |
0.0002 |
| 836 |
HAEMATOMA |
4 |
0.0002 |
| 837 |
SKIN EXFOLIATION |
13 |
0.0002 |
| 838 |
DEAFNESS |
4 |
0.0002 |
| 839 |
ECZEMA |
8 |
0.0002 |
| 840 |
MEMORY IMPAIRMENT |
21 |
0.0002 |
| 841 |
MUSCULOSKELETAL PAIN |
8 |
0.0002 |
| 842 |
JOINT STIFFNESS |
4 |
0.0002 |
| 843 |
CHOLELITHIASIS |
5 |
0.0002 |
| 844 |
EYE DISORDER |
5 |
0.0002 |
| 845 |
DISORIENTATION |
6 |
0.0002 |
| 846 |
THERAPEUTIC RESPONSE SHORTENED |
5 |
0.0002 |
| 847 |
BALANCE DISORDER |
13 |
0.0002 |
| 848 |
LIP SWELLING |
5 |
0.0001 |
| 849 |
SKIN DISORDER |
5 |
0.0001 |
| 850 |
DRY SKIN |
20 |
0.0001 |
| 851 |
IRRITABILITY |
9 |
0.0001 |
| 852 |
CARDIAC FAILURE |
12 |
0.0001 |
| 853 |
TYPE 2 DIABETES MELLITUS |
5 |
0.0001 |
| 854 |
INTENTIONAL PRODUCT USE ISSUE |
13 |
0.0001 |
| 855 |
INJURY ASSOCIATED WITH DEVICE |
3 |
0.0001 |
| 856 |
CONSTIPATION |
32 |
0.0001 |
| 857 |
GAIT DISTURBANCE |
28 |
0.0001 |
| 858 |
CORONARY ARTERY OCCLUSION |
2 |
0.0001 |
| 859 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 860 |
HYPONATRAEMIA |
8 |
0.0001 |
| 861 |
RENAL FAILURE ACUTE |
6 |
0.0001 |
| 862 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
5 |
0.0001 |
| 863 |
IRRITABLE BOWEL SYNDROME |
3 |
0.0001 |
| 864 |
NEUTROPENIA |
19 |
0.0001 |
| 865 |
MOBILITY DECREASED |
10 |
0.0001 |
| 866 |
PRURITUS GENERALISED |
3 |
0.0001 |
| 867 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
3 |
0.0001 |
| 868 |
VAGINAL HAEMORRHAGE |
6 |
0.0001 |
| 869 |
ANOSMIA |
2 |
0.0001 |
| 870 |
PANIC ATTACK |
5 |
0.0001 |
| 871 |
APATHY |
2 |
0.0001 |
| 872 |
DYSSTASIA |
4 |
0.0001 |
| 873 |
PULMONARY EMBOLISM |
13 |
0.0001 |
| 874 |
CARDIOMYOPATHY |
2 |
0.0001 |
| 875 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 876 |
RASH MACULO-PAPULAR |
3 |
0.0001 |
| 877 |
DRUG INEFFECTIVE |
176 |
0.0001 |
| 878 |
EPILEPSY |
4 |
0.0001 |
| 879 |
SHOCK |
3 |
0.0001 |
| 880 |
DRUG ADMINISTRATION ERROR |
4 |
0.0001 |
| 881 |
HYPOKALAEMIA |
6 |
0.0001 |
| 882 |
ACUTE MYELOID LEUKAEMIA |
2 |
0.0001 |
| 883 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
9 |
0.0001 |
| 884 |
PANCYTOPENIA |
7 |
0.0001 |
| 885 |
THROMBOCYTOPENIA |
14 |
0.0001 |
| 886 |
METABOLIC ACIDOSIS |
4 |
0.0001 |
| 887 |
CEREBROVASCULAR ACCIDENT |
21 |
0.0001 |
| 888 |
EMOTIONAL DISTRESS |
15 |
0.0001 |
| 889 |
LACTIC ACIDOSIS |
4 |
0.0001 |
| 890 |
FIBROMYALGIA |
3 |
0.0001 |
| 891 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
25 |
0.0001 |
| 892 |
BLINDNESS |
5 |
0.0001 |
| 893 |
IMPAIRED HEALING |
4 |
0.0001 |
| 894 |
GASTROINTESTINAL HAEMORRHAGE |
10 |
0.0001 |
| 895 |
BONE PAIN |
7 |
0.0001 |
| 896 |
HOT FLUSH |
9 |
0.0001 |
| 897 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 898 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
| 899 |
CATARACT |
7 |
0.0001 |
| 900 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 901 |
THERAPEUTIC RESPONSE DECREASED |
7 |
0.0001 |
| 902 |
DEVICE DEFECTIVE |
2 |
0.0001 |
| 903 |
DEVICE LEAKAGE |
5 |
0.0001 |
| 904 |
DEVICE USE ERROR |
4 |
0.0001 |
| 905 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 906 |
INJECTION SITE BRUISING |
9 |
0.0001 |
| 907 |
LIVER DISORDER |
5 |
0.0001 |
| 908 |
SKIN BURNING SENSATION |
8 |
0.0001 |
| 909 |
PULMONARY OEDEMA |
5 |
0.0001 |
| 910 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 911 |
TREATMENT NONCOMPLIANCE |
6 |
0.0001 |
| 912 |
ACCIDENTAL OVERDOSE |
4 |
0.0001 |
| 913 |
DEEP VEIN THROMBOSIS |
7 |
0.0001 |
| 914 |
DYSGEUSIA |
8 |
0.0001 |
| 915 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 916 |
DIABETES MELLITUS |
8 |
0.0001 |
| 917 |
DEATH |
89 |
0.0001 |
| 918 |
HYPOGLYCAEMIA |
5 |
0.0001 |
| 919 |
LABORATORY TEST ABNORMAL |
3 |
0.0001 |
| 920 |
INSOMNIA |
27 |
0.0001 |
| 921 |
INJECTION SITE HAEMORRHAGE |
8 |
0.0001 |
| 922 |
CYTOKINE RELEASE SYNDROME |
2 |
0.0001 |
| 923 |
PREMATURE BABY |
3 |
0.0001 |
| 924 |
CONFUSIONAL STATE |
16 |
0.0001 |
| 925 |
STOMATITIS |
6 |
0.0001 |
| 926 |
PLEURAL EFFUSION |
6 |
0.0001 |
| 927 |
OSTEOPOROSIS |
4 |
0.0001 |
| 928 |
FEMUR FRACTURE |
3 |
0.0001 |
| 929 |
NERVOUSNESS |
5 |
0.0001 |
| 930 |
CARDIO-RESPIRATORY ARREST |
4 |
0.0001 |
| 931 |
DERMATITIS |
2 |
0.0001 |
| 932 |
RENAL IMPAIRMENT |
8 |
0.0001 |
| 933 |
NIGHT SWEATS |
3 |
0.0001 |
| 934 |
DISTURBANCE IN ATTENTION |
5 |
0.0001 |
| 935 |
DEPRESSION |
21 |
0.0001 |
| 936 |
AMNESIA |
6 |
0.0001 |
| 937 |
HAEMATOCHEZIA |
5 |
0.0001 |
| 938 |
VISUAL ACUITY REDUCED |
3 |
0.0001 |
| 939 |
URINARY RETENTION |
3 |
0.0001 |
| 940 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
4 |
0.0001 |
| 941 |
THERAPY NON-RESPONDER |
4 |
0.0001 |
| 942 |
CONVULSION |
5 |
0.0001 |
| 943 |
HYPERKALAEMIA |
3 |
0.0001 |
| 944 |
DEVICE MALFUNCTION |
6 |
0.0001 |
| 945 |
ACUTE KIDNEY INJURY |
13 |
0.0001 |
| 946 |
DISEASE PROGRESSION |
10 |
0.0001 |
| 947 |
BLOOD GLUCOSE DECREASED |
4 |
0.0001 |
| 948 |
RENAL FAILURE |
11 |
0.0001 |
| 949 |
DRUG INTOLERANCE |
8 |
0.0001 |
| 950 |
UNDERDOSE |
6 |
0.0001 |
| 951 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 952 |
AGITATION |
6 |
0.0001 |
| 953 |
ALOPECIA |
16 |
0.0001 |
| 954 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 955 |
AGEUSIA |
2 |
0.0001 |
| 956 |
RHEUMATOID ARTHRITIS |
9 |
0.0001 |
| 957 |
ACCIDENTAL EXPOSURE TO PRODUCT |
8 |
0.0001 |
| 958 |
ABORTION SPONTANEOUS |
3 |
0.0001 |
| 959 |
DRUG EFFECT DECREASED |
4 |
0.0001 |
| 960 |
DEVICE BREAKAGE |
3 |
0.0001 |
| 961 |
DEMENTIA |
2 |
0.0001 |
| 962 |
ANGINA PECTORIS |
2 |
0.0001 |
| 963 |
ACNE |
5 |
0.0001 |
| 964 |
BLOOD CHOLESTEROL INCREASED |
3 |
0.0001 |
| 965 |
COGNITIVE DISORDER |
3 |
0.0001 |
| 966 |
MYOCARDIAL INFARCTION |
11 |
0.0001 |
| 967 |
FEBRILE NEUTROPENIA |
4 |
0.0001 |
| 968 |
ANGER |
2 |
0.0001 |
| 969 |
DELIRIUM |
2 |
0.0001 |
| 970 |
INTENTIONAL PRODUCT MISUSE |
5 |
0.0001 |
| 971 |
VISUAL IMPAIRMENT |
7 |
0.0001 |
| 972 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 973 |
BREAST CANCER |
5 |
0.0001 |
| 974 |
HALLUCINATION |
4 |
0.0001 |
| 975 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 976 |
PRODUCT DOSE OMISSION |
3 |
0.0000 |
| 977 |
SUICIDAL IDEATION |
4 |
0.0000 |
| 978 |
COMA |
2 |
0.0000 |
| 979 |
COLORECTAL CANCER |
2 |
0.0000 |
| 980 |
OVERDOSE |
9 |
0.0000 |
| 981 |
CHRONIC KIDNEY DISEASE |
3 |
0.0000 |
| 982 |
MALIGNANT NEOPLASM PROGRESSION |
4 |
0.0000 |
| 983 |
PSORIASIS |
5 |
0.0000 |
| 984 |
DRY MOUTH |
3 |
0.0000 |
| 985 |
FOETAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 986 |
DRUG DOSE OMISSION |
6 |
0.0000 |
| 987 |
TOXICITY TO VARIOUS AGENTS |
5 |
0.0000 |